|
Tao-Cheng Wu, M.D. |
Education: |
- Institute of Clinical Medicine, National Yang-Ming University
|
................................................................................................................................. |
Current Positions: |
- Attending physician, Department of internal medicine, Dividion of cardiology, Taipei Veterans General Hospital
|
|
............................................................................................................................................................................................... |
Faculty: |
- Associate Professor of medicine, Faculty of medicine, National Yang-Ming University
|
............................................................................................................................................................................................... |
Experience:
|
- Resident training in Internal Medicine in Taipei Veterans General Hospital
|
............................................................................................................................................................................................... |
Specialist Certificate: |
- License of internal medicine, Taiwan
|
.............................................................................................................................................................................................. |
Medical Expertise: |
- General cardiology
- Cardiovascular Imaging
- Hypertension
- Cardiomyopathy Heart Failure
|
............................................................................................................................................................................................... |
E-mail: |
|
.............................................................................................................................................................................................. |
Important Publication: |
- Wu TC, Chiang CY, Chan JS, Lee CY, Leu HB, Huang PH, Chen JS, Lin SJ, Chen JW. Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways. J Interferon Cytokine Res. 2018;38(11):510-516.
- Wu TC, Chang CC, Leu HB, Huang PH, Lin SJ, Chen JW. Phorbol ester-induced angiogenesis of endothelial progenitor cells: The role of NADPH oxidase-mediated, redox-related matrix metalloproteinase pathways. PLoS One. 2019;14(1):e0209426.
- Wu TC, Chang WH, Lu HY, Shih CC. Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection. Wu TC, et al. Vascul Pharmacol. 2022;144:106973.
- Wu TC, Chen JS, Wang CH, Huang PH, Lin FY, Lin LY, Lin SJ, Chen JW. Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair. Sci Rep. 2019; 9(1):17316.
- Lee CY, Lin SJ, Wu TC. miR-548j-5p regulates angiogenesis in peripheral artery disease. Sci Rep. 2022;12(1):838.
限於篇幅,以上謹為代表著作
|
|